Home » Senesco Opens New Clinical Trial Site at Seattle Cancer Care Alliance
Senesco Opens New Clinical Trial Site at Seattle Cancer Care Alliance
Senesco has enrolled its first patients at a new clinical trial site in Seattle. The company is beginning a Phase Ib/IIa trial of its SNS01-T drug for B-cell cancer.
Pharmaceutical Business Review
Pharmaceutical Business Review
Upcoming Events
-
07May
-
14May
-
30May